BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7075130)

  • 1. Routine use of hyoscine N butylbromide (Buscopan) in double contrast barium enema examinations.
    Lee JR
    Clin Radiol; 1982 May; 33(3):273-6. PubMed ID: 7075130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spasmolytic effect of peppermint oil in barium during double-contrast barium enema compared with Buscopan.
    Asao T; Kuwano H; Ide M; Hirayama I; Nakamura JI; Fujita KI; Horiuti R
    Clin Radiol; 2003 Apr; 58(4):301-5. PubMed ID: 12662951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antispasmodic drugs in double contrast barium enema examination: glucagon or buscopan?
    Goei R; Nix M; Kessels AH; Ten Tusscher MP
    Clin Radiol; 1995 Aug; 50(8):553-7. PubMed ID: 7656523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of timing of intravenous muscle relaxant on the quality of double-contrast barium enema.
    Elson EM; Campbell DM; Halligan S; Shaikh I; Davitt S; Bartram CI
    Clin Radiol; 2000 May; 55(5):395-7. PubMed ID: 10816408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of buscopan on adverse reactions to intravascular contrast media.
    Sharma S; Rajani M; Khosla A; Misra N; Goulatia RK
    Br J Radiol; 1989 Dec; 62(744):1056-8. PubMed ID: 2605452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hyoscine butylbromide on gastroesophageal reflux in barium studies of the upper gastrointestinal tract.
    McLoughlin RF; Mathieson JR; Chipperfield PM; Grymaloski MR; Wong AD
    Can Assoc Radiol J; 1994 Dec; 45(6):452-4. PubMed ID: 7982106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ocular effects of hyoscine-n-butylbromide ("Buscopan") in radiological practice.
    Sissons GR; McQueenie A; Mantle M
    Br J Radiol; 1991 Jul; 64(763):584-6. PubMed ID: 1873658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon distension, perceived burden and side-effects of CT-colonography for screening using hyoscine butylbromide or glucagon hydrochloride as bowel relaxant.
    de Haan MC; Boellaard TN; Bossuyt PM; Stoker J
    Eur J Radiol; 2012 Aug; 81(8):e910-6. PubMed ID: 22683196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral hyoscine butylbromide for irritable bowel syndrome?
    MacRae KD
    Br Med J; 1979 Mar; 1(6165):752. PubMed ID: 435771
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral hyoscine butylbromide for irritable bowel syndrome?
    Herxheimer A; Misiewicz JJ
    Br Med J; 1979 Mar; 1(6165):752. PubMed ID: 435770
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient diverticula of the colon.
    Rawlinson J; Brunton FJ
    Br J Radiol; 1989 Jan; 62(733):27-30. PubMed ID: 2914188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral hyoscine butylbromide for irritable bowel syndrome?
    Gibbons D
    Br Med J; 1979 Mar; 1(6165):752. PubMed ID: 435769
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of paralysing agents in double-contrast barium meal examinations.
    Heron CW; Lynn AH; Marshall JH; Mason RR
    Clin Radiol; 1985 Jul; 36(4):391-3. PubMed ID: 4064532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Motoractivity of the colon in radiological picture. II. Effect of Buscopan on colonic emptying from contrast enema (author's transl)].
    Smigielska-Stolarczyk E
    Pol Przegl Radiol Med Nukl; 1976; 40(1):33-6. PubMed ID: 942536
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of irritable colon. Efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon].
    Schäfer E; Ewe K
    Fortschr Med; 1990 Aug; 108(25):488-92. PubMed ID: 2210587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyoscine-N-butylbromide (Buscopan) as a duodenal relaxant in tubeless duodenography.
    Ayre-Smith G
    Acta Radiol Diagn (Stockh); 1976 Sep; 17(5B):701-13. PubMed ID: 790897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the pharmacologic effect and clinical use of hyoscine-N-butylbromide (buscopan)].
    HEINKEL K
    Dtsch Z Verdau Stoffwechselkr; 1951 Jul; 11(4):180-95. PubMed ID: 14872696
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose reduction of hyoscine-N-butylbromide for double-contrast barium meal examinations--a prospective randomized study.
    Massoud TF; Nolan DJ
    Clin Radiol; 1992 Nov; 46(5):340-3. PubMed ID: 1464208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effect of the spasmolytic agent hyoscine N-butylbromide (buscopan) in so-called spastic bronchitis in infants].
    GADEKE R
    Kinderarztl Prax; 1955 Nov; 23(11):486-92. PubMed ID: 13279076
    [No Abstract]   [Full Text] [Related]  

  • 20. The evidence for using hyoscine N-butylbromide (Buscopan) in ureteric obstruction.
    Bourdoumis A; Stasinou T; Papadopoulos G; Buchholz N
    Int J Clin Pract; 2014 Sep; 68(9):1174. PubMed ID: 25196183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.